CareVax Vaccine Tracking Program Launches

CareVax Vaccine tracking program designed to support the millions of individuals that will receive the COVID-19 vaccine has been launched by Care Angel.

CareVax patients will be given access to vaccine and COVID-19 education through ANGEL, a digital workforce of virtual nurse assistants that gathers clinical and non-clinical information, and when necessary, automatically triages users to the appropriate healthcare resources to address post-inoculation care needs. Powered by the company’s SmartCare Ecosystem Platform, ANGEL has the ability to augment the capacity of already exhausted clinical resources by 100X+ or more in order to manage and monitor for COVID-19 and vaccination symptoms for populations at scale, using omni-channels such as phone, text and chat.

“Before the pandemic, there had been already a massive global shortage of nurses, providers and family caregivers. This unprecedented global health crisis has exacerbated these human resources beyond capacity and caused an unnecessary caregiving burden leading to unrelenting suffering, deaths, long-term health and mental health issues, not to mention tremendous isolation for the aging, the sick and neediest populations,” said Lena Nikolnikov, Vice President of Product & Clinical Solutions at Care Angel.

CareVax is being released in the US first, internationally in early Q1, and is poised to work with government public health agencies at the federal, state, local county, and city levels offering a data-driven solution that can provide real-time analytic, surveillance and market intelligence in order to make more informed care decisions.

The program can be deployed stand alone or along with Care Angel’s HEALS COVID engagement and tracking offerings for employers and schools intended to help track and monitor at-risk populations, including exposure to COVID-19 positive cases and the need to quarantine. The initiative empowers vulnerable individuals with personalized health management, monitoring, education, contact tracing and triage to testing as well as care navigation.

Demand for scalable, quickly deployable solutions to manage large populations has accelerated due to the combination of the COVID-19 pandemic, vaccination distribution and the shortage of providers and care teams, domestically and across the world.

“After millions of calls and texts tracking COVID-19 in 2020, we see 2021 as a pivotal year for Care Angel to help globally as the critical need for resources that can deliver meaningful healthcare conversations at scale has been thrust into the global spotlight,” said Wolf Shlagman, CEO of Care Angel. “Sitting squarely at the intersection of digital health, telemedicine, AI and COVID-19, working with some of the largest health organizations on the planet, we are proud to already be having a noticeable impact on public health and the health and safety of society’s most vulnerable populations.”

Care Angel partners with large health plans, providers, health systems, pharma and government agencies to tackle some of the most challenging and costly elements of healthcare, namely, care management, health monitoring and reporting for vulnerable and at-risk populations.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.